THERAPASE
Dead / Cancelled — Cancelled — Section 8 (as of 25 Aug 2017)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77306027
- Registration number
- 3906108
- Mark type
- Stylized text
- Filed
- 17 Oct 2007
- Published for opposition
- 27 Jan 2009
- Registered
- 18 Jan 2011
- Attorney of record
- Jeffrey M. Gitchel
Goods and services
- Class 001 — Chemicals: Biochemical substances for scientific and research use, namely, proteins and nucleic acids with enzyme and ribozyme properties; assays for molecular-biological research, namely, kits composed of chemical reagents for non-medical purposes
- Class 005 — Pharmaceuticals: Pharmaceutical products based on active proteins and nucleic acids for use in treating autoimmune and inflammation diseases, diseases of the blood and lymphatic system, cancer, cardiovascular and circulatory diseases, diseases of the central nervous system, dental diseases, dermatology disorders, diseases of the digestive system, genetic diseases, infections, diseases of the kidney and genitourinary system, metabolic diseases, endocrinology diseases, musculoskeletal disorders, ophthalmology diseases, respiratory and pulmonary diseases and gynecological diseases; diagnostic preparations for veterinary purposes based on active proteins and nucleic acids; medical diagnostic kits primarily composed of reagents and assays for testing amniotic fluid, blood and blood plasma, serum, semen, urine, cerebrospinal fluid and intracellular fluid, saliva, sputum, feces, lymphatic fluid, wound exudate and sanies
- Class 042 — Scientific and technological services: Scientific research and development in the field of molecular biology and providing advice on a contractual bases relating to scientific developments in molecular biology; scientific research and development of molecular-biological assays; scientific research and development of medicine and environmental analysis; scientific research and development in the fields of biological active substances and biotechnology
Owner
- BAYER INTELLECTUAL PROPERTY GMBH, MONHEIM AM RHEIN, DE
- BAYER PHARMA AKTIENGESELLSCHAFT, BERLIN, DE
- BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, BERLIN, DE
- BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, BERLIN, DE
- DIREVO BioTech AG, Köln, DE
- DIREVO BioTech AG, Köln, DE
Prosecution history
- 25 Aug 2017 — CANCELLED SEC. 8 (6-YR)
- 10 Aug 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Jan 2016 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Dec 2013 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Jan 2011 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Jan 2011 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Jan 2011 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2010 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 29 Oct 2010 — NOTICE OF ALLOWANCE CANCELLED
- 29 Oct 2010 — TEAS DELETE 1(B) BASIS RECEIVED
- 25 Aug 2010 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Aug 2010 — SOU EXTENSION 3 GRANTED
- 23 Aug 2010 — SOU EXTENSION 3 FILED
- 23 Aug 2010 — SOU TEAS EXTENSION RECEIVED
- 23 Feb 2010 — SOU EXTENSION 2 GRANTED